🇺🇸 FDA

Company profile · Sponsor

Century

Century Therapeutics

IPSC · NYSE biotech PHILADELPHIA, PA, USA
Pipeline
10
Drugs
0
Patents
8

Quick answer

Century (IPSC) is a biotech company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker IPSC
Exchange NYSE
Company type biotech
Headquarters PHILADELPHIA, PA, USA
SEC CIK 0001850119

Pipeline (10)

Search pipeline →

  1. Aspirin 75 mg daily

    Century

    Intracerebral Haemorrhage

    phase 3 small molecule active

    1 trial

  2. Stromal-vascular fraction

    Century

    Knee Osteoarthritis

    phase 2 mab active

    1 trial

  3. X-22 Smoking Cessation Product

    Century

    Smoking Cessation

    phase 2 small molecule completed

    1 trial

  4. A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product

    Century

    Hematological or solid tumor malignancies or autoimmune diseases

    phase 1 other active

    1 trial

  5. CNTY-101

    Century

    R/R CD19-Positive B-Cell Malignancies

    phase 1 mab terminated

    1 trial

  6. CNTY-101

    Century

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  7. Nicotine gum (C)

    Century

    Tobacco Use

    phase 1 small molecule completed

    2 trials

  8. The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune Diseases

    Century

    systemic lupus erythematosus [SLE]/lupus nephritis [LN], idiopathic inflammatory myopathy [IIM], and diffuse cutaneous systemic sclerosis [DcSSc]

    phase 1 other active

    1 trial

  9. DAOSiN®/ Placebo & ProvokAmin® Ingestion

    Century

    Histamine Intolerance

    other completed

    1 trial

  10. Early auto-mode

    Century

    Diabetes Mellitus Type 1 Pre-Existing

    other completed

    1 trial

Patents (8)

Search patents →

  1. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12084670

    Regulating alkaloids

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11667924

    Increasing levels of nicotinic alkaloids in plants

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Century?

Century (IPSC) is a biotech company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Century sponsor?

We track 10 ClinicalTrials.gov-linked programs for Century, including Aspirin 75 mg daily and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Century company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.